Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis
Authors
Keywords
-
Journal
Mucosal Immunology
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-16
DOI
10.1038/s41385-019-0132-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
- (2018) Celine Hernandez et al. JOURNAL OF CLINICAL INVESTIGATION
- Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert
- (2018) Geoffrey Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High mobility group box 1 orchestrates tissue regeneration via CXCR4
- (2017) Mario Tirone et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of CDK4/6 protects against radiation-induced intestinal injury in mice
- (2016) Liang Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- Host-Microbiome Cross-talk in Oral Mucositis
- (2016) R.M. Vasconcelos et al. JOURNAL OF DENTAL RESEARCH
- Radioprotective Agents: Strategies and Translational Advances
- (2016) Mohammad Zahid Kamran et al. MEDICINAL RESEARCH REVIEWS
- β-Arrestin1 inhibits chemotherapy-induced intestinal stem cell apoptosis and mucositis
- (2016) Y Zhan et al. Cell Death & Disease
- Secreted HMGB1 from Wnt activated intestinal cells is required to maintain a crypt progenitor phenotype
- (2016) Karen R. Reed et al. Oncotarget
- High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells
- (2016) Yu-Ching Chen et al. Scientific Reports
- MD-2 is required for disulfide HMGB1–dependent TLR4 signaling
- (2015) Huan Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release
- (2015) Keon-Il Im et al. JOURNAL OF IMMUNOLOGY
- N-acetyl cysteine for prevention of oral mucositis in hematopoietic SCT: a double-blind, randomized, placebo-controlled trial
- (2014) A Moslehi et al. BONE MARROW TRANSPLANTATION
- Dysfunctional HIV-Specific CD8+ T Cell Proliferation Is Associated with Increased Caspase-8 Activity and Mediated by Necroptosis
- (2014) Gaurav D. Gaiha et al. IMMUNITY
- IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice
- (2014) R Guabiraba et al. Mucosal Immunology
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome
- (2014) Naoki Takemura et al. Nature Communications
- TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species
- (2013) Francisco J. Roca et al. CELL
- HMGB1 in Cancer: Good, Bad, or Both?
- (2013) R. Kang et al. CLINICAL CANCER RESEARCH
- Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection
- (2013) Wei-Jie Zhou et al. NATURE
- Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis
- (2013) Gangwen Han et al. NATURE MEDICINE
- Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants
- (2012) J D Goldberg et al. BONE MARROW TRANSPLANTATION
- mTOR Inhibition Prevents Epithelial Stem Cell Senescence and Protects from Radiation-Induced Mucositis
- (2012) Ramiro Iglesias-Bartolome et al. Cell Stem Cell
- HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease
- (2012) Helena Erlandsson Harris et al. Nature Reviews Rheumatology
- Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner
- (2011) Matthew A Ciorba et al. GUT
- Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study
- (2011) Quynh-Thu Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial
- (2011) Michael Henke et al. JOURNAL OF CLINICAL ONCOLOGY
- The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations
- (2011) K. S. Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NecroX as a novel class of mitochondrial reactive oxygen species and ONOO− scavenger
- (2010) Hyoung Jin Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- New thoughts on the initiation of mucositis
- (2010) ST Sonis ORAL DISEASES
- R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/ -catenin pathway
- (2009) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PUMA Regulates Intestinal Progenitor Cell Radiosensitivity and Gastrointestinal Syndrome
- (2008) Wei Qiu et al. Cell Stem Cell
- Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma
- (2008) David M. Brizel et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now